Banque Transatlantique’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.1M Buy
35,317
+1,986
+6% +$232K 0.09% 83
2026
Q1
$4.02M Buy
33,331
+14,503
+77% +$1.67M 0.1% 63
2025
Q4
$1.98M Sell
18,828
-4,575
-20% -$429K 0.05% 71
2025
Q3
$1.96M Sell
23,403
-30
-0.1% -$2.47K 0.05% 73
2025
Q2
$1.86M Sell
23,433
-200
-0.8% -$15.9K 0.05% 66
2025
Q1
$2.12M Sell
23,633
-1,678
-7% -$157K 0.06% 62
2024
Q4
$2.51M Buy
+25,311
New +$2.61M 0.06% 58

Other funds holding MRK

Banque Transatlantique's MRK Position: Q2 2026 in Review

Banque Transatlantique increased its Merck (MRK) stake by 6% in Q2 2026, buying an estimated $232K and bringing the position to 35,317 shares worth $4.1M. The position accounts for 0.09% of the portfolio, ranked #83.

Banque Transatlantique first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 2,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Banque Transatlantique held 35,317 shares of Merck worth $4.1M as of Q2 2026.
  • Banque Transatlantique bought 1,986 Merck shares in Q2 2026, an estimated $232K.
  • Merck made up 0.09% of Banque Transatlantique's portfolio in Q2 2026, its #83 holding.
  • Banque Transatlantique first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 2,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.